Toward the elimination of lymphatic filariasis by 2020: treatment update and impact assessment for the endgame.
about
Prospects and challenges of CRISPR/Cas genome editing for the study and control of neglected vector-borne nematode diseasesCessation of mass drug administration for lymphatic filariasis in Zanzibar in 2006: was transmission interrupted?Maternal Infection Is a Risk Factor for Early Childhood Infection in FilariasisMaternal Filarial Infection Influences the Development of Regulatory T Cells in Children from Infancy to Early ChildhoodShort-Course, High-Dose Rifampicin Achieves Wolbachia Depletion Predictive of Curative Outcomes in Preclinical Models of Lymphatic Filariasis and Onchocerciasis.Examining the role of macrolides and host immunity in combatting filarial parasites.The global distribution and transmission limits of lymphatic filariasis: past and present.This de-wormed world?Heterogeneous dynamics, robustness/fragility trade-offs, and the eradication of the macroparasitic disease, lymphatic filariasisMeasuring elimination of podoconiosis, endemicity classifications, case definition and targets: an international Delphi exercise.Antifilarial activity of diterpenoids from Taxodium distichum.Modelling the distribution and transmission intensity of lymphatic filariasis in sub-Saharan Africa prior to scaling up interventions: integrated use of geostatistical and mathematical modelling.Human Leukocytes Kill Brugia malayi Microfilariae Independently of DNA-Based Extracellular Trap Release.Mass Drug Administration and beyond: how can we strengthen health systems to deliver complex interventions to eliminate neglected tropical diseases?Essential proteins and possible therapeutic targets of Wolbachia endosymbiont and development of FiloBase--a comprehensive drug target database for Lymphatic filariasis.Diagnosis of a malayan filariasis case using a shotgun diagnostic metagenomics assay.Coverage of, and compliance with, mass drug administration under the programme to eliminate lymphatic filariasis in India: a systematic review.An investigation of the disparity in estimates of microfilaraemia and antigenaemia in lymphatic filariasis surveys.Understanding the relationship between prevalence of microfilariae and antigenaemia using a model of lymphatic filariasis infection.Shrinking the lymphatic filariasis map: update on diagnostic tools for mapping and transmission monitoring.Ivermectin: a complimentary weapon against the spread of malaria?Quantifying filariasis and malaria control activities in relation to lymphatic filariasis elimination: a multiple intervention score map (MISM) for Malawi.Identifying co-endemic areas for major filarial infections in sub-Saharan Africa: seeking synergies and preventing severe adverse events during mass drug administration campaigns.Results of a confirmatory mapping tool for Lymphatic filariasis endemicity classification in areas where transmission was uncertain in Ethiopia.Differential susceptibilities of Anopheles albimanus and Anopheles stephensi mosquitoes to ivermectin.Environmental suitability for lymphatic filariasis in NigeriaPerceived threat and benefit toward community compliance of filariasis’ mass drug administration in Pekalongan district, Indonesia
P2860
Q28074596-350ED5AC-D357-44F1-B4B6-03E6E0C02ECDQ28545122-38312926-C2E7-41B4-8660-59A6E58911DBQ28546891-28107A38-BB8A-4794-A353-482777652469Q28553589-E38C68F7-BACB-46B0-87BD-FC242522F484Q30377066-AF50F09D-4566-44B0-A4DE-8A1CF6D1C44CQ33564559-25D1F6AD-C394-40A6-82E1-859877E58F6AQ34340088-BB0D5F7C-5678-4F6B-9451-53C172089AC7Q34986489-1A3EB0B1-19F6-44FC-A638-7C84F033C5BCQ35907642-D09A79C3-3D01-46AB-BDD3-2A1C3E122376Q35998408-8655E305-5FD8-4E63-8F63-8F3A99AB1E2CQ36035115-B82DFF88-4559-4C4F-8CB0-1BEAEDE2BADCQ36204671-83805887-69C1-4E8F-86C8-14DCD5574BADQ36237787-101C26AC-2B47-4E06-92A6-904DF925E995Q36303982-6267FC47-965B-4836-BE4D-F3A7C7DCB0DFQ36500880-7BB714FA-DDB6-4E86-9E10-E60E25A35A5AQ36583688-0D8CBC43-37D9-46CB-A072-BC235EE8058EQ38204263-AF5DB78C-DB7A-42BB-8422-7D7ED98A366CQ38535058-9E0462E3-5FEF-4E61-B8B6-47B5B2EC82B0Q39095216-4D03AC85-86A8-4E97-A64A-4B402EB1D0F8Q39388274-86A3A235-6D5C-478A-B729-970FB4FD004EQ40411509-DF86E0FB-2865-4385-8C23-1E797A198873Q46716665-A4417B05-21C8-4034-AD40-264DA97DC2C1Q48139837-EB1BEB55-21EF-4367-8F89-E4F87459340EQ52631148-BF2D315A-ECA0-4707-9904-015999A79481Q53419052-A923F357-5AB0-4EE5-9E19-35B798D7B4BCQ58733445-58CE4B77-0145-4E29-8170-5D8B46681F55Q59135437-6BD2B88B-51A6-4F66-804B-1877EA36029D
P2860
Toward the elimination of lymphatic filariasis by 2020: treatment update and impact assessment for the endgame.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Toward the elimination of lymp ...... ct assessment for the endgame.
@en
type
label
Toward the elimination of lymp ...... ct assessment for the endgame.
@en
prefLabel
Toward the elimination of lymp ...... ct assessment for the endgame.
@en
P2860
P1476
Toward the elimination of lymp ...... ct assessment for the endgame.
@en
P2093
Maria P Rebollo
Moses J Bockarie
P2860
P304
P356
10.1586/14787210.2013.811841
P577
2013-07-01T00:00:00Z